Skip to content
Disclosery

EXANE DERIVATIVES: RNG position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on RNG, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 673 RNG shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 673 shares
    Change vs previous 13F 0 shares

    0.02% of the 13F portfolio, value $35,164.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 673 shares
    Change vs previous 13F +536 shares

    0.02% of the 13F portfolio, value $78,877.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 137 shares
    Change vs previous 13F -43 shares

    0.01% of the 13F portfolio, value $25,666.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 180 shares
    Change vs previous 13F -237 shares

    0.01% of the 13F portfolio, value $39,149.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 417 shares
    Change vs previous 13F +126 shares

    0.03% of the 13F portfolio, value $117,904.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 291 shares
    Change vs previous 13F -2,802 shares

    0.03% of the 13F portfolio, value $86,679.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 3,093 shares
    Change vs previous 13F -209 shares

    0.36% of the 13F portfolio, value $1,172,100.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 3,302 shares
    Change vs previous 13F not available

    0.3% of the 13F portfolio, value $906,712.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).